Diagnostics (May 2023)

Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?

  • Adele Valentini,
  • Paola Franchi,
  • Giuseppe Cicchetti,
  • Gaia Messana,
  • Greta Chiffi,
  • Cecilia Strappa,
  • Lucio Calandriello,
  • Annemilia del Ciello,
  • Alessandra Farchione,
  • Lorenzo Preda,
  • Anna Rita Larici

DOI
https://doi.org/10.3390/diagnostics13091607
Journal volume & issue
Vol. 13, no. 9
p. 1607

Abstract

Read online

Pulmonary hypertension (PH) is a pathophysiological disorder, defined by a mean pulmonary arterial pressure (mPAP) > 20 mmHg at rest, as assessed by right heart catheterization (RHC). PH is not a specific disease, as it may be observed in multiple clinical conditions and may complicate a variety of thoracic diseases. Conditions associated with the risk of developing PH are categorized into five different groups, according to similar clinical presentations, pathological findings, hemodynamic characteristics, and treatment strategy. Most chronic lung diseases that may be complicated by PH belong to group 3 (interstitial lung diseases, chronic obstructive pulmonary disease, combined pulmonary fibrosis, and emphysema) and are associated with the lowest overall survival among all groups. However, some of the chronic pulmonary diseases may develop PH with unclear/multifactorial mechanisms and are included in group 5 PH (sarcoidosis, pulmonary Langerhans’ cell histiocytosis, and neurofibromatosis type 1). This paper focuses on PH associated with chronic lung diseases, in which radiological imaging—particularly computed tomography (CT)—plays a crucial role in diagnosis and classification. Radiologists should become familiar with the hemodynamical, physiological, and radiological aspects of PH and chronic lung diseases in patients at risk of developing PH, whose prognosis and treatment depend on the underlying disease.

Keywords